Amgen, BMS and Merck have the most exposure as Big Pharma eyes $183B patent cliff: analyst 0 15.07.2024 18:04 Fiercepharma.com Amgen, BMS and Merck have the most exposure as Big Pharma eyes $183B patent cliff: analyst kdunleavy Mon, 07/15/2024 - 11:04
